Evidence map›Paper›PMID 36832185›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Application Prospects of FTIR Spectroscopy and CLSM to Monitor the Drugs Interaction with Bacteria Cells Localized in Macrophages for Diagnosis and Treatment Control of Respiratory Diseases.

Igor D Zlotnikov, Alexander A Ezhov, Maksim A Vigovskiy, Olga A Grigorieva, Uliana D Dyachkova, Natalia G Belogurova, Elena V Kudryashova

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Lesion Detection and Analysis Using Optical Imaging.Diagnostics (Basel, Switzerland) · 2023
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Igor D ZlotnikovFaculty of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.ORCID 0000-0002-2497-0859
Alexander A EzhovFaculty of Physics, Lomonosov Moscow State University, Leninskie Gory, 1/2, 119991 Moscow, Russia.ORCID 0000-0001-6221-3093
Maksim A VigovskiyMedical Research and Education Center, Institute for Regenerative Medicine, Lomonosov Moscow State University, 27/10, Lomonosovsky Ave., 119192 Moscow, Russia.ORCID 0000-0003-2103-8158
Olga A GrigorievaMedical Research and Education Center, Institute for Regenerative Medicine, Lomonosov Moscow State University, 27/10, Lomonosovsky Ave., 119192 Moscow, Russia.
Uliana D DyachkovaMedical Research and Education Center, Institute for Regenerative Medicine, Lomonosov Moscow State University, 27/10, Lomonosovsky Ave., 119192 Moscow, Russia.
Natalia G BelogurovaFaculty of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
Elena V KudryashovaFaculty of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.ORCID 0000-0002-9761-7757
Lomonosov Moscow State University · RU

Funding

Russian Science Foundation 22-24-00604
6 · The paper itself

Abstract

Visualization of the interaction of drugs with biological cells creates new approaches to improving the bioavailability, selectivity, and effectiveness of drugs. The use of CLSM and FTIR spectroscopy to study the interactions of antibacterial drugs with latent bacterial cells localized in macrophages create prospects to solve the problems of multidrug resistance (MDR) and severe cases. Here, the mechanism of rifampicin penetration into

Indexed as

CLSMdrug resistanceFTIR spectroscopylatent infectionmacrophage

Identifiers

PMID36832185
PMCPMC9954918
OpenAlexW4320497507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.